. Most items comprising these measures evaluate active movement in the distal regions of the affected arm. However, their intervention targeted shoulder movement. Thus, there is a mismatch between the movement abilities that the ARAT and FAI measure and the target of the study intervention.
similar, whereas statistically 4 weeks, we find it remarkable that the length of stay was 44% longer in the intervention group. Is it possible that the intervention group was more impaired, but the measures did not sensitively reflect this? Moreover, because subjects were all acute stroke survivors, many presumably received concomitant therapies during and after discharge. Is it possible that the control group received more follow-up therapy than the intervention group? Confounds are more plausible explanations for the lack of difference at end of treatment but a significant difference at 3 months.
Given these methodological limitations, the study results and conclusions are seriously flawed. Given the preponderance of evidence, sNMES remains a promising intervention for shoulder dysfunction for a select group of stroke survivors, especially with respect to pain. 3 We are particularly concerned that results of this poorly designed study will negatively impact sNMES reimbursement and clinical use and be a major disservice to a subset of patients who might benefit from this modality.
